在早产后晚发性败血症的结果预测
Francesca Miselli1,2, Riccardo Cuoghi Costantini3, Melissa Maugeri4
1PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Via Università, 41121, Modena, Italy. 79638@studenti.unimore.it.
Pediatric research
|January 17, 2025
概括
一个新的模型使用诊断时可用的数据估计了晚发性败血症 (LOS) 的早产婴儿死亡和脑损伤的风险. 这种工具有助于临床医生早期识别和量身定制的管理,以获得更好的结果.
科学领域:
- 新生儿医学 新生儿医学
- 儿童传染病 儿童传染病
- 临床风险预测预测
背景情况:
- 在早产婴儿中,晚发性败血症 (LOS) 具有显著的死亡和脑损伤风险.
- 早期识别高风险新生儿对于及时有效的干预至关重要.
- 目前的方法缺乏客观的工具,在怀疑败血症时立即分层风险.
研究的目的:
- 开发一种定量模型,用于估计LOS的早产婴儿死亡和/或脑损伤的直接风险.
- 为了利用毒症怀疑时可获得的客观,可测量的数据 (血液培养收集).
- 帮助临床医生根据个人风险概况量身定制管理策略.
主要方法:
- 追溯性研究,包括在妊娠36周以下出生的新生儿,在72小时后血/脑脊液培养物呈阳性.
- 分析临床数据,包括产后年龄,平均血压和乳酸水平.
- 开发和验证一个多变量预测模型,用于糟糕的结果.
主要成果:
- 该研究包括94名早产婴儿,其中27.7%的结果不佳 (死亡或脑损伤).
- 结果差的婴儿平均血压显著降低,乳酸盐水平更高.
- 开发的模型表现出良好的区分 (c-statistic=0.8618) 和校准,将患者分为低,中和高风险组.
结论:
- 预测模型是早期识别早产新生儿的实用工具,这些新生儿在LOS中面临着不良结果的高风险.
- 它使临床医生能够及时实施积极的支持和密切监测.
- 早期风险分层化有助于个性化管理,可能改善新生儿败血症的预后.
相关概念视频
01:30Pneumonia III: Complications and Assessment
153
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
153
01:30Pneumonia I: Introduction
205
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
01:28Pneumonia IV: Management
296
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
296